רבלימיד 15 מ"ג

国: イスラエル

言語: ヘブライ語

ソース: Ministry of Health

有効成分:

LENALIDOMIDE 15 MG

から入手可能:

NEOPHARM SCIENTIFIC LTD

ATCコード:

L04AX04

医薬品形態:

CAPSULES

投与経路:

PER OS

製:

CELGENE EUROPE LTD, UK

治療群:

LENALIDOMIDE

適応症:

1. Treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. In combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.

承認日:

2009-04-01